Genpact Limited
G · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.20 | 10.86 | -2.70 | 2.02 |
| FCF Yield | 3.97% | 1.99% | 0.20% | 2.39% |
| EV / EBITDA | 36.67 | 39.55 | 45.42 | 37.16 |
| Quality | ||||
| ROIC | 3.41% | 3.03% | 3.27% | 3.60% |
| Gross Margin | 36.37% | 35.88% | 35.31% | 35.70% |
| Cash Conversion Ratio | 2.11 | 1.34 | 0.31 | 1.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.16% | 3.79% | 3.37% | 2.93% |
| Free Cash Flow Growth | 91.16% | 755.49% | -90.23% | -12.91% |
| Safety | ||||
| Net Debt / EBITDA | 3.05 | 4.01 | 4.12 | 3.50 |
| Interest Coverage | 14.99 | 9.96 | 10.38 | 9.22 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 85.47 | 88.99 | 86.86 | 84.65 |